Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Drug Discovery (6)
182 Articles Available
6
8
Can't find what you're looking for? Try our
advanced search
.
Oncology
Stopping Cancer Cell Division Using Targeted Enzyme Control
PAO-M02-18-NI-001
Biosimilars
Novartis Makes More Biosimilar Moves
PAO-M01-18-NI-047
Vaccine
EMA Committee Gives Positive Recommendation to GSK’s Shingles Vaccine
PAO-M01-18-NI-046
CAR-T
Pfizer Joins Gilead in CAR-T Development
PAO-M01-18-NI-044
Drug Discovery
X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca
PR-M01-18-NI-073
Biosimilar
European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
PR-M01-18-NI-077
Bioprinting
Sebaceous Glands in 3D
PAO-M01-18-NI-029
Pulmonx Submits Premarket Approval (PMA) Application to U.S. FDA for Zephyr Endobronchial Valve as Treatment for Emphysema
PR-M01-18-NI-039
Strategic Collaboration
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
PR-M01-18-NI-033
Development Agreement
Arvinas Protein Degradation Technology Attracts Pfizer’s Attention
PAO-M01-18-NI-020
Cannibis
California Legalizes Cannabis with Canada Looming
PR-M01-18-NI-030
Oncology Research
Global BioLife, a Biomedical Subsidiary of Singapore eDevelopment Limited, Completes Cancer Research for New Universal Therapeutic Drug Platform
PR-M01-18-NI-028
Biologics
New Class of Exosome Biologics Focuses on Stroke Treatment
PAO-M01-18-NI-011
Drug Discovery
Defense Department Commits $16 Million to Fight Bacterial Bioweapons
PAO-M01-18-NI-010
Business
Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases
PR-M01-18-NI-009
Acquisition
Gilead’s new Kite Subsidiary To Buy CAR-T Cell Therapy Company Cell Design Labs
PAO-M01-18-NI-001
Biosimilars
Pfizer Receives FDA Approval for Remicade® Biosimilar
PAO-M12-17-NI-039
DNA
New Method Could Provide Super Resolution for Biological Imaging
PAO-M12-17-NI-040
Chemistry
Hot Electrons Might Enable New Synthetic Methods
PAO-M12-17-NI-039
Drug Delivery
Needle-Free Injection Technology Advances to Phase II Trial
PAO-M12-17-NI-035
Artificial Intelligence
New Platform Brings AI Efficiency to Health Data Processing
PAO-M12-17-NI-036
Investment
Transporters Targeting Cell’s Metabolic Gates Win Financing
PAO-M12-17-NI-037
Drug Delivery
Needle-Free Injection Technology Advances to Phase II Trial
PAO-M12-17-NI-035
FDA
NDA Submitted for Antimalarial Drug
PAO-M12-17-NI-034
«
6
8
»
.svg)
